|
시장보고서
상품코드
1964211
유동성 지혈제 시장 규모, 점유율, 성장 분석 : 지혈제 유형별, 적용 분야별, 제제 유형별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)Flowable Hemostats Market Size, Share, and Growth Analysis, By Type of Hemostat, By Application Area, By Formulation Type, By End User, By Region - Industry Forecast 2026-2033 |
||||||
세계의 유동성 지혈제 시장 규모는 2024년에 7억 8,877만 달러로 평가되었고, 2025년 8억 5,976만 달러에서 2033년까지 17억 1,312만 달러로 성장할 전망입니다. 또한 예측 기간(2026-2033년) CAGR은 9.0%를 나타낼 것으로 예측됩니다.
세계 유동성 지혈제 시장은 주로 수술 건수 증가와 수술의 복잡성 증가에 따라 효율적인 수술 중 출혈 관리에 대한 수요 증가가 주요 촉진요인으로 작용하고 있습니다. 젤라틴 트롬빈 매트릭스와 같은 주사용 또는 가소성 국소 약물은 기존 방법으로는 대응하기 어려운 불규칙한 창상에도 적합합니다. 그 효과로 인해 수혈의 필요성을 최소화하고, 수술 시간을 단축하며, 합병증 발생률을 낮출 수 있습니다. 이 시장은 저침습적 기술의 발전과 규제 당국의 강조를 배경으로 기존의 거즈나 분말에서 특수 제제로 전환하고 있습니다. 수술이 점점 더 복잡해짐에 따라 신속한 지혈을 보장하는 유동성 지혈제에 대한 수요가 증가하고 있으며, 병원은 임상적, 경제적 이점으로 인해 이러한 제품을 우선적으로 채택하고 있으며, 이는 신흥 시장에서의 혁신과 파트너십의 길을 열어주고 있습니다.
유동성 지혈제 세계 시장 성장 촉진요인
수술 건수 증가와 더 복잡한 중재적 수술의 보급으로 인해 효율적인 출혈 제어 솔루션에 대한 임상적 수요가 증가하고 있습니다. 이에 따라 의료진들은 불규칙한 상처 형태에 적응하고 신속한 적용이 가능한 유동성 지혈제를 선택하는 경향이 강해지고 있습니다. 외과 의사들은 수술 중 출혈을 최소화하고 최소 침습 기술을 향상시킬 수 있는 신뢰할 수 있는 도구를 점점 더 많이 찾고 있으며, 의료 기관에서는 수술의 효율성과 환자 결과 개선에 기여하는 제품을 우선시하는 추세가 나타나고 있습니다. 이러한 임상적 추세는 다양한 외과적 전문 분야에서의 폭넓은 수용과 함께 병원 처방에 유동성 지혈제의 채택 빈도를 증가시켜 시장의 내생적 성장을 가속하고 있습니다.
세계 유동성 지혈제 시장 성장 억제요인
유동성 지혈제 세계 시장은 지역별로 복잡하고 다양한 규제 요건으로 인해 심각한 문제에 직면해 있습니다. 이러한 규제는 특히 혁신적인 생물학적 성분이나 독특한 전달 메커니즘을 가진 유동성 지혈제의 경우, 제품 출시가 지연되거나 시장 침투를 제한하는 요인이 될 수 있습니다. 제조업체는 종종 긴 심사 과정을 거쳐야 하며, 안전성과 유효성에 대한 광범위한 데이터를 제공해야 합니다. 이는 개발 노력을 복잡하게 만들고, 상업화 이니셔티브에서 자원을 재분배하는 결과를 초래합니다. 이러한 문제는 중소기업 시장 진입을 저해하고, 신제품 처방에 대한 투자를 지연시킬 수 있으며, 궁극적으로 최첨단 지혈 솔루션의 임상 적용 속도에 영향을 미칠 수 있습니다.
세계 유동성 지혈제 시장 동향
세계 유동성 지혈제 시장은 최소침습 수술 기술 및 로봇 수술의 도입 확대에 따라 괄목할 만한 성장세를 보이고 있습니다. 이러한 추세는 복잡한 해부학적 구조에 효과적으로 적응하고 제한된 공간에서 빠른 지혈을 실현할 수 있는 지혈 솔루션을 임상의들이 요구하고 있으며, 수술의 효율성 향상에 기여하고 있습니다. 병원에서는 환자의 입원 기간 단축과 수술 효율 최적화에 기여하는 제품의 우선순위가 높아지고 있습니다. 이에 따라 각 제조업체는 포장 개선, 적용 기기와의 호환성 향상, 종합적인 교육 지원 등 수술 워크플로우에 원활하게 통합될 수 있는 기술 혁신을 통해 현대 외과 의료의 진화하는 요구에 부응하는 뚜렷한 우위를 창출하고 있습니다.
자주 묻는 질문
목차
서론
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 유동성 지혈제 시장 규모 : 지혈제 유형별&CAGR(2026-2033)
세계의 유동성 지혈제 시장 규모 : 응용 분야별&CAGR(2026-2033)
세계의 유동성 지혈제 시장 규모 : 제제 유형별&CAGR(2026-2033)
세계의 유동성 지혈제 시장 규모 : 최종사용자별&CAGR(2026-2033)
세계의 유동성 지혈제 시장 규모&CAGR(2026-2033)
경쟁 정보
주요 기업 개요
결론과 제안
LSH 26.03.19Global Flowable Hemostats Market size was valued at USD 788.77 Million in 2024 and is poised to grow from USD 859.76 Million in 2025 to USD 1713.12 Million by 2033, growing at a CAGR of 9.0% during the forecast period (2026-2033).
The global flowable hemostats market is primarily driven by the rising demand for efficient intraoperative bleeding control amid increasing surgical procedures and their complexity. These injectable or malleable topical agents, such as gelatin-thrombin matrices, conform to irregular wound beds where traditional methods fail. Their effectiveness minimizes the need for blood transfusions, shortens operating times, and reduces complication rates. This market has transitioned from conventional gauzes and powders to specialized formulations, propelled by the rise of minimally invasive techniques and regulatory emphasis. As surgical complexities grow, the demand for flowable hemostats that ensure rapid hemostasis intensifies, prompting hospitals to prioritize these products for their clinical and economic benefits, thus opening avenues for innovation and partnerships in emerging markets.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Flowable Hemostats market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Flowable Hemostats Market Segments Analysis
Global flowable hemostats market is segmented by type of hemostat, application area, formulation type, end user and region. Based on type of hemostat, the market is segmented into Fibrin-based Hemostats, Collagen-based Hemostats and Gelatin-based Hemostats. Based on application area, the market is segmented into Trauma Cases, Cardiovascular Surgery, Orthopedic Surgery and Others. Based on formulation type, the market is segmented into Liquid Formulations and Powder Formulations. Based on end user, the market is segmented into Hospitals, Ambulatory Surgical Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Flowable Hemostats Market
The rising number of surgical procedures and more intricate interventions has led to a greater clinical demand for efficient bleeding control solutions, encouraging healthcare professionals to opt for flowable hemostats that adapt to irregular wound shapes and allow for quick application. Surgeons are increasingly seeking dependable tools to minimize intraoperative blood loss and enhance minimally invasive techniques, resulting in a trend within healthcare institutions to prioritize products that boost procedural efficiency and improve patient outcomes. This clinical inclination, coupled with broader acceptance across various surgical specialties, is driving more frequent inclusion of flowable hemostats in hospital formularies, thus promoting organic market growth.
Restraints in the Global Flowable Hemostats Market
The Global Flowable Hemostats market faces significant challenges due to complex and diverse regulatory requirements that vary by region. These regulations can hinder timely product launches and limit market penetration, especially for flowable hemostats featuring innovative biologic components or proprietary delivery mechanisms. Manufacturers are often required to navigate lengthy review processes and provide extensive data on safety and efficacy, which complicates development efforts and reallocates resources away from commercialization initiatives. Such challenges can deter smaller companies from entering the market and slow down investment in new product formulations, ultimately affecting the speed at which cutting-edge hemostatic solutions become available for clinical use.
Market Trends of the Global Flowable Hemostats Market
The Global Flowable Hemostats market is experiencing significant growth due to the escalating adoption of minimally invasive surgical techniques and robotic procedures. This trend is fueled by a clinician preference for hemostatic solutions that can effectively conform to intricate anatomies and deliver rapid hemostasis in limited spaces, thereby enhancing surgical efficacy. Hospitals are increasingly prioritizing products that contribute to shorter patient stays and optimized throughput. In response, manufacturers are innovating with improved packaging, applicator compatibility, and comprehensive training support to streamline integration into surgical workflows, creating distinct advantages that cater to the evolving demands of modern surgical practices.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Flowable Hemostats Market Size by Type of Hemostat & CAGR (2026-2033)
- Market Overview
- Fibrin-based Hemostats
- Collagen-based Hemostats
- Gelatin-based Hemostats
Global Flowable Hemostats Market Size by Application Area & CAGR (2026-2033)
- Market Overview
- Trauma Cases
- Cardiovascular Surgery
- Orthopedic Surgery
- Others
Global Flowable Hemostats Market Size by Formulation Type & CAGR (2026-2033)
- Market Overview
- Liquid Formulations
- Powder Formulations
Global Flowable Hemostats Market Size by End User & CAGR (2026-2033)
- Market Overview
- Hospitals
- Ambulatory Surgical Centers
- Others
Global Flowable Hemostats Market Size & CAGR (2026-2033)
- North America (Type of Hemostat, Application Area, Formulation Type, End User)
- US
- Canada
- Europe (Type of Hemostat, Application Area, Formulation Type, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Type of Hemostat, Application Area, Formulation Type, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Type of Hemostat, Application Area, Formulation Type, End User)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Type of Hemostat, Application Area, Formulation Type, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Johnson & Johnson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medtronic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- B. Braun Melsungen AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ethicon
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Baxter International Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cardinal Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Z-Medica
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Integra LifeSciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- MILS Biologics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CryoLife
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- C. R. Bard
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sanofi
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hemostasis, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Source BioScience
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Teleflex Incorporated
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Stryker Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Terumo Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Grifols S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Acelity L.P. Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
